Skip to main content
Sharon Riddler, MD, Infectious Disease, Pittsburgh, PA, UPMC Magee-Womens Hospital

SharonARiddlerMD

Infectious Disease Pittsburgh, PA

HIV/AIDS Medicine

Professor, Medicine, University of Pittsburgh School of Medicine

Dr. Riddler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Riddler's full profile

Already have an account?

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Infectious Disease, 1991 - 1994
  • University of Missouri-Kansas City School of Medicine
    University of Missouri-Kansas City School of MedicineResidency, Internal Medicine, 1986 - 1990
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 1986

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1991 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring  
    Sharon Riddler, MD, Clinical Infectious Diseases

Press Mentions

  • Minimal Antibody Response in Imbokodo Compels Change of Course for HIV Vaccine Research
    Minimal Antibody Response in Imbokodo Compels Change of Course for HIV Vaccine ResearchJuly 31st, 2022
  • Trial of Three mRNA HIV Vaccines Launched
    Trial of Three mRNA HIV Vaccines LaunchedMarch 15th, 2022
  • Westmoreland Commissioners to Host 2nd Info Session on Covid-19 Vaccine
    Westmoreland Commissioners to Host 2nd Info Session on Covid-19 VaccineMarch 29th, 2021
  • Join now to see all

Grant Support

  • Immunotherapy With Autologous Hiv-Loaded Dendritic CellsNational Institute Of Allergy And Infectious Diseases2010–2011
  • RAND PHI Eval Immuniz W/Highly Conserved HIV-1 DER PEPT Influ MatrixNational Center For Research Resources2005
  • An Assessment Of Oral Mucosal Immunity In HIV-1 Infection - Version 10National Center For Research Resources2005
  • ACTG A5079: A Prospective, Multicenter, Randomized, Placebo-Controlled Trial OfNational Center For Research Resources2005
  • ACTG A5142: A Phase III, Randomized, Open-Label Comparison Of Lopinavir/National Center For Research Resources2004–2005
  • Immuniz. W/Highly Conserved HIV-1 Der. Influ. MatrixNational Center For Research Resources2004
  • Assessment Of Oral Mucosal Immunity In HIV-1 InfectionNational Center For Research Resources2004
  • A Prospective Analysis Of Body Composition In Men Enrolled In The MulticenterNational Center For Research Resources2004
  • T 20 W/ Abacavir Amprenavir, Ritonavir, Efavirenz In HIVNational Center For Research Resources2000–2002
  • Multicenter 34 Week Study Of Invinavir/Nelfinavir In HIV 1 Seropositive PatientsNational Center For Research Resources1998–2000
  • Double Blind Placebo Controlled Study Of DMP 266 And Indinvir In HIV+ PatientsNational Center For Research Resources1997–1999

Hospital Affiliations